VIM
ABBV icon

VELA Investment Management’s AbbVie ABBV Stock Holding History

VELA Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Buy
+1,000
New +$222K 0.05% 169
2025
Q4 		– Sell
-5,000
Closed -$1.16M – 169
2025
Q3 		$1.16M Hold
5,000
– – 0.28% 108
2025
Q2 		$928K Buy
+5,000
New +$929K 0.25% 112

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VELA Investment Management's ABBV Position: Q1 2026 in Review

VELA Investment Management reduced its AbbVie (ABBV) stake by 67% in Q1 2026, selling an estimated $1.11M and leaving 2,454 shares worth $534K. The position accounts for 0.12% of the portfolio, ranked #142.

VELA Investment Management first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.95M in Q1 2023. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • VELA Investment Management held 2,454 shares of AbbVie worth $534K as of Q1 2026.
  • VELA Investment Management sold 4,991 AbbVie shares in Q1 2026, an estimated $1.11M.
  • AbbVie made up 0.12% of VELA Investment Management's portfolio in Q1 2026, its #142 holding.
  • VELA Investment Management first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • VELA Investment Management's AbbVie position peaked at $2.95M in Q1 2023.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on VELA Investment Management's 13F filing for Q1 2026, filed 8 May 2026.